0000885590-11-000014.txt : 20110411
0000885590-11-000014.hdr.sgml : 20110408
20110411112329
ACCESSION NUMBER: 0000885590-11-000014
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20100928
FILED AS OF DATE: 20110411
DATE AS OF CHANGE: 20110411
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 905 286-3000
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGRAM ROBERT ALEXANDER
CENTRAL INDEX KEY: 0001219890
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 11751880
MAIL ADDRESS:
STREET 1: 1605 CURTIS BRIDGE ROAD
CITY: WILKESBORO
STATE: NC
ZIP: 28697
FORMER NAME:
FORMER CONFORMED NAME: INGRAM ROBERT A
DATE OF NAME CHANGE: 20030222
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4/A
2010-09-28
2010-09-30
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001219890
INGRAM ROBERT ALEXANDER
C/O 7150 MISSISSAUGA ROAD
MISSISSAUGA
A6
L5N 8M5
ONTARIO, CANADA
1
0
0
0
Common Stock, no par value
2010-09-28
4
A
0
210449
0
A
210449
D
Common Stock, no par value
2010-09-28
4
A
0
9872
0
A
220321
D
Represents restricted share units received upon conversion of a portion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") restricted stock units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the merger agreement between the issuer and, amongst others, old Valeant. The restricted share units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share.
This amendment is being filed to correct the number of restricted share units that were reported in the original filing.
Represents common shares received upon conversion of the reporting person's remaining old Valeant restricted stock units that were held prior to the Merger (i.e. those that were not converted into restricted share units as described in Footnote 1), in accordance with the terms of the merger agreement. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share.
By: Angie Palmer for Robert A. Ingram
2011-04-11